je.st
news
Tag: diabetes
Diabetes drug helps people lose weight: study
2015-07-02 09:00:52| Biotech - Topix.net
Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, helped obese people lose an average of 18 pounds , a yearlong study said. Most patients were able to keep the weight off for the duration of the 56-week study on the drug marketed as Saxenda by Novo Nordisk, according to the findings published in the New England Journal of Medicine.
Tags: people
study
weight
drug
PharmaCyte Biotech's Cancer and Diabetes Treatments Airing Nationwide on Discovery Channel
2015-06-29 14:55:41| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , announced today that its technology and treatments will be featured on the Discovery Channel and ION Network tomorrow morning, June 30, 2015, from 7:00-7:30 a.m. EDT and PDT, except on DISH Network which airs using the EDT time zone. PharmaCyte Biotech's story will air on Discovery Channel and ION Network's news magazine series "NewsWatch," a source for breaking consumer, technology, travel, health and entertainment news since 1990.
Tags: channel
cancer
discovery
nationwide
Startup aims to upend diabetes care with matchstick-size implant
2015-06-15 17:52:44| Food - Topix.net
A tiny, matchstick-size pump, which could be implanted for up to a year in diabetics, is showing promise as a replacement for self-administered shots.
Tags: care
aims
diabetes
startup
Startup aims to upend diabetes care with matchstick-size implant
2015-06-15 17:50:08| Agriculture - Topix.net
A tiny, matchstick-size pump, which could be implanted for up to a year in diabetics, is showing promise as a replacement for self-administered shots.
Tags: care
aims
diabetes
startup
PharmaCyte Biotech's Diabetes Treatment to Be Presented at Austrodrugs 2015
2015-06-12 21:11:19| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today reported that the company's diabetes treatment and the research program of its international Diabetes Consortium will be presented at the Austrodrugs 2015 conference to be held on June 12 in Vienna, Austria. The Austrodrugs conference is one of the leading disease treatment development meetings in central Europe.
Tags: presented
treatment
diabetes
biotechs
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »